Immunotherapeutic Strategies - Key Publications



Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.


  • Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction

    Simpson AA, Mohammed F, Salim M, Tranter A, Rickinson AB, Stauss HJ, Moss PA, Steven NM, Willcox BE.

    Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21176-81. doi: 10.1073/pnas.1108422109. Epub 2011 Dec 12.

  • Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

    Steele JC, Rao A, Marsden JR, Armstrong CJ, Berhane S, Billingham LJ, Graham N, Roberts C, Ryan G, Uppal H, Walker C, Young LS, Steven NM.

    Gene Ther. 2011 Jun;18(6):584-93.

  • Shear stress, tip cells and regulators of endothelial migration.

    Zhuang X, Cross D, Heath VL, Bicknell R.

    Biochem Soc Trans. 2011 Dec;39(6):1571-5.

  • Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

    Bendle GM, Linnemann C, Hooijkaas AI, Bies L, de Witte MA, Jorritsma A, Kaiser AD, Pouw N, Debets R, Kieback E, Uckert W, Song JY, Haanen JB, Schumacher TN.

    Nat Med. 2010 May;16(5):565-70, 1p following 570

  • Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.

    De Santo C, Arscott R, Booth S, Karydis I, Jones M, Asher R, Salio M, Middleton M, Cerundolo V.

    Nat Immunol. 2010 Nov;11(11):1039-46.

  • CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus

    Elmetwali T, Searle PF, McNeish I, Young LS, Palmer DH.

    Mol Cancer. 2010 Mar 8;9:52.